Regions Financial Corp’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-342
| Closed | -$203K | – | 907 |
|
|
2026
Q1 | $203K | Sell |
342
-168
| -33% | -$83.7K | ﹤0.01% | 835 |
|
|
2025
Q4 | $248K | Sell |
510
-117
| -19% | -$54.5K | ﹤0.01% | 764 |
|
|
2025
Q3 | $263K | Buy |
+627
| New | +$211K | ﹤0.01% | 755 |
|
|
2024
Q4 | – | Sell |
-561
| Closed | -$201K | – | 858 |
|
|
2024
Q3 | $201K | Buy |
+561
| New | +$190K | ﹤0.01% | 806 |
|
|
2023
Q2 | – | Sell |
-950
| Closed | -$213K | – | 860 |
|
|
2023
Q1 | $213K | Sell |
950
-5
| -0.5% | -$1.23K | ﹤0.01% | 773 |
|
|
2022
Q4 | $266K | Sell |
955
-119
| -11% | -$30K | ﹤0.01% | 717 |
|
|
2022
Q3 | $225K | Sell |
1,074
-40
| -4% | -$8.94K | ﹤0.01% | 740 |
|
|
2022
Q2 | $263K | Sell |
1,114
-194
| -15% | -$39.4K | ﹤0.01% | 742 |
|
|
2022
Q1 | $235K | Sell |
1,308
-22
| -2% | -$4.19K | ﹤0.01% | 837 |
|
|
2021
Q4 | $287K | Sell |
1,330
-22
| -2% | -$4.32K | ﹤0.01% | 790 |
|
|
2021
Q3 | $250K | Sell |
1,352
-77
| -5% | -$15.2K | ﹤0.01% | 805 |
|
|
2021
Q2 | $256K | Sell |
1,429
-97
| -6% | -$18.5K | ﹤0.01% | 803 |
|
|
2021
Q1 | $255K | Sell |
1,526
-195
| -11% | -$32.5K | ﹤0.01% | 752 |
|
|
2020
Q4 | $261K | Buy |
+1,721
| New | +$226K | ﹤0.01% | 722 |
|
|
2020
Q3 | – | Sell |
-2,220
| Closed | -$268K | – | 836 |
|
|
2020
Q2 | $268K | Buy |
+2,220
| New | +$250K | ﹤0.01% | 669 |
|
|
2019
Q2 | – | Sell |
-180
| Closed | -$21K | – | 1679 |
|
|
2019
Q1 | $21K | Hold |
180
| – | – | ﹤0.01% | 1355 |
|
|
2018
Q4 | $20K | Hold |
180
| – | – | ﹤0.01% | 1358 |
|
|
2018
Q3 | $23K | Hold |
180
| – | – | ﹤0.01% | 1424 |
|
|
2018
Q2 | $20K | Hold |
180
| – | – | ﹤0.01% | 1467 |
|
|
2018
Q1 | $20K | Hold |
180
| – | – | ﹤0.01% | 1473 |
|
|
2017
Q4 | $27K | Buy |
+180
| New | +$22.9K | ﹤0.01% | 1420 |
|
|
2014
Q4 | – | Sell |
-1,967
| Closed | -$253K | – | 1027 |
|
|
2014
Q3 | $253K | Sell |
1,967
-398
| -17% | -$41K | ﹤0.01% | 989 |
|
|
2014
Q2 | $209K | Buy |
+2,365
| New | +$227K | ﹤0.01% | 1061 |
|
|
2014
Q1 | – | Sell |
-2,847
| Closed | -$322K | – | 1142 |
|
|
2013
Q4 | $322K | Buy |
+2,847
| New | +$257K | ﹤0.01% | 913 |
|
|
2013
Q3 | – | Sell |
-5,157
| Closed | -$340K | – | 1098 |
|
|
2013
Q2 | $340K | Buy |
+5,157
| New | +$332K | ﹤0.01% | 841 |
|
Other funds holding UTHR
ACA
JT
Regions Financial Corp's UTHR Position: Q2 2026 in Review
Regions Financial Corp sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 342 shares — an estimated $203K sold.
Regions Financial Corp first reported a position in UTHR in Q2 2013 and held it in 25 quarters. The position peaked at $340K in Q2 2013. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Regions Financial Corp reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
- Regions Financial Corp sold 342 United Therapeutics shares in Q2 2026, an estimated $203K.
- Regions Financial Corp first reported a position in United Therapeutics in Q2 2013 and held it in 25 quarters.
- Regions Financial Corp's United Therapeutics position peaked at $340K in Q2 2013.
- 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.